STOCK TITAN

Precision Optics Corporation Schedules Second Quarter of Fiscal Year 2024 Conference Call for Wednesday, February 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Precision Optics Corporation, Inc. (Nasdaq: POCI) has scheduled a conference call to discuss its second quarter of fiscal year 2024 financial results. The call will take place on Wednesday, February 14, 2024, at 5:00pm ET. Interested parties can access the call through dial-in information or a live webcast. The Company intends to release its financial results and file its 10-Q after the close of the market on the same day, followed by the conference call.
Positive
  • None.
Negative
  • None.

GARDNER, Mass., Feb. 8, 2024 /PRNewswire/ -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that it has scheduled a conference call to discuss second quarter of fiscal year 2024 financial results on Wednesday, February 14, 2024, at 5:00pm ET.

The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, February 14, 2024, followed by the conference call.

Conference Call Details

Date and Time: Wednesday, February 14, 2024, at 5:00pm ET

Call-in Information: Interested parties can access the conference call by dialing (844) 735-3662 or
(412) 317-5705.

Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available at https://app.webinar.net/5l19x2DzRKG.

Replay: A teleconference replay of the call will be available until February 21, 2024, at (877) 344-7529 or (412) 317-0088, replay access code 9304851. A webcast replay will be available at https://app.webinar.net/5l19x2DzRKG.  

About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics and imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture.  Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Lighthouse Imaging division's electronic imaging expertise and its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company designs and manufactures next-generation product solutions to meet the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery, including single-use medical devices, as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies with a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company's future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by the Company's management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company's annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law. 

Company Contact:                                                   
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800

Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/precision-optics-corporation-schedules-second-quarter-of-fiscal-year-2024-conference-call-for-wednesday-february-14-2024-302058077.html

SOURCE Precision Optics Corporation

FAQ

When is Precision Optics Corporation, Inc.'s conference call to discuss its second quarter of fiscal year 2024 financial results scheduled?

The conference call is scheduled for Wednesday, February 14, 2024, at 5:00pm ET.

How can interested parties access the conference call?

Interested parties can access the conference call by dialing (844) 735-3662 or (412) 317-5705.

Is there a live webcast available for the conference call?

Yes, interested parties can access the conference call via a live webcast, available at https://app.webinar.net/5l19x2DzRKG.

Will there be a replay of the conference call available?

Yes, a teleconference replay of the call will be available until February 21, 2024, at (877) 344-7529 or (412) 317-0088, replay access code 9304851. A webcast replay will also be available at https://app.webinar.net/5l19x2DzRKG.

Precision Optics Corporation, Inc.

NASDAQ:POCI

POCI Rankings

POCI Latest News

POCI Stock Data

32.74M
4.85M
24.86%
32.15%
0.07%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GARDNER